On September 6, 2022 Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, reported that members of management will present at two upcoming investor conferences. Details are as follows (Press release, Mersana Therapeutics, SEP 6, 2022, View Source [SID1234619023]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Morgan Stanley 20th Annual Global Healthcare Conference
Format: Fireside Chat
Date/Time: Monday, September 12, 2022, at 4:15 p.m. Eastern Time

Baird 2022 Global Healthcare Conference
Format: Fireside Chat
Date/Time: Tuesday, September 13, 2022, at 2:00 p.m. Eastern Time
A live webcast of the fireside chat at the Morgan Stanley 20th Annual Global Healthcare Conference will be available on the Investors & Media section of Mersana’s website at www.mersana.com. An archived replay will be available for approximately 90 days following the event.